Presence of the anti-leukemic nucleotide analog, 2-chloro-2′-deoxyadenosine-5′-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP)

William R. Hartman, D. Eric Walters, Patricia Hentosh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

2-Chlorodeoxyadenosine (CldAdo, Cladribine), a nucleoside analog used in the treatment of hairy cell leukemia, is phosphorylated and incorporated into DNA, but is not an absolute chain terminator. We hypothesized that the presence of a chlorine molecule projecting into the DNA minor groove would affect DNA:protein-binding interactions. Here, we investigated recognition of and binding to double-stranded CldAMP-substituted TATA promoter sequences by human TATA-binding protein (TBP) using mobility shift assays. Depending on the site, CldAMP in place of dAMP within a TATA sequence decreased in vitro TBP binding by ∼30% to 55% compared to control sites. When bound to a CldAMP-substituted TATA box, however, the TBP complex was more resistant to polyanions, suggesting enhanced stability. Limited exposure of the TBP:DNA complex to proteases indicated that TBP conformation was altered on CldAMP-substituted DNA compared to control. Further, binding of transcription factor IIB to TBP was diminished on analog-containing TATA sequences. These results suggest normal TBP-binding interactions-specifically recognition, stability, and conformation-are disrupted by CldAMP insertion into eukaryotic promoter sequences.

Original languageEnglish (US)
Pages (from-to)223-232
Number of pages10
JournalArchives of Biochemistry and Biophysics
Volume459
Issue number2
DOIs
StatePublished - Mar 15 2007
Externally publishedYes

Fingerprint

TATA-Box Binding Protein
DNA sequences
Nucleotides
Cladribine
DNA
Protein Binding
Conformations
Transcription Factor TFIIB
Hairy Cell Leukemia
Protein Conformation
TATA Box
Chlorine
DNA-Binding Proteins
Electrophoretic Mobility Shift Assay
2'-deoxy-5'-adenosine monophosphate
Nucleosides
Assays
Peptide Hydrolases
Cells
Molecules

Keywords

  • Cancer drug
  • Cladribine
  • DNA minor groove
  • Hairy cell leukemia
  • Promoter sequence
  • Protein conformation
  • Protein:protein associations
  • RNA polymerase II
  • TATA-binding protein
  • Transcription factors

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Presence of the anti-leukemic nucleotide analog, 2-chloro-2′-deoxyadenosine-5′-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP). / Hartman, William R.; Walters, D. Eric; Hentosh, Patricia.

In: Archives of Biochemistry and Biophysics, Vol. 459, No. 2, 15.03.2007, p. 223-232.

Research output: Contribution to journalArticle

@article{c7be9973ab404f558bad0da0c878c64b,
title = "Presence of the anti-leukemic nucleotide analog, 2-chloro-2′-deoxyadenosine-5′-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP)",
abstract = "2-Chlorodeoxyadenosine (CldAdo, Cladribine), a nucleoside analog used in the treatment of hairy cell leukemia, is phosphorylated and incorporated into DNA, but is not an absolute chain terminator. We hypothesized that the presence of a chlorine molecule projecting into the DNA minor groove would affect DNA:protein-binding interactions. Here, we investigated recognition of and binding to double-stranded CldAMP-substituted TATA promoter sequences by human TATA-binding protein (TBP) using mobility shift assays. Depending on the site, CldAMP in place of dAMP within a TATA sequence decreased in vitro TBP binding by ∼30{\%} to 55{\%} compared to control sites. When bound to a CldAMP-substituted TATA box, however, the TBP complex was more resistant to polyanions, suggesting enhanced stability. Limited exposure of the TBP:DNA complex to proteases indicated that TBP conformation was altered on CldAMP-substituted DNA compared to control. Further, binding of transcription factor IIB to TBP was diminished on analog-containing TATA sequences. These results suggest normal TBP-binding interactions-specifically recognition, stability, and conformation-are disrupted by CldAMP insertion into eukaryotic promoter sequences.",
keywords = "Cancer drug, Cladribine, DNA minor groove, Hairy cell leukemia, Promoter sequence, Protein conformation, Protein:protein associations, RNA polymerase II, TATA-binding protein, Transcription factors",
author = "Hartman, {William R.} and Walters, {D. Eric} and Patricia Hentosh",
year = "2007",
month = "3",
day = "15",
doi = "10.1016/j.abb.2006.12.031",
language = "English (US)",
volume = "459",
pages = "223--232",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Presence of the anti-leukemic nucleotide analog, 2-chloro-2′-deoxyadenosine-5′-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP)

AU - Hartman, William R.

AU - Walters, D. Eric

AU - Hentosh, Patricia

PY - 2007/3/15

Y1 - 2007/3/15

N2 - 2-Chlorodeoxyadenosine (CldAdo, Cladribine), a nucleoside analog used in the treatment of hairy cell leukemia, is phosphorylated and incorporated into DNA, but is not an absolute chain terminator. We hypothesized that the presence of a chlorine molecule projecting into the DNA minor groove would affect DNA:protein-binding interactions. Here, we investigated recognition of and binding to double-stranded CldAMP-substituted TATA promoter sequences by human TATA-binding protein (TBP) using mobility shift assays. Depending on the site, CldAMP in place of dAMP within a TATA sequence decreased in vitro TBP binding by ∼30% to 55% compared to control sites. When bound to a CldAMP-substituted TATA box, however, the TBP complex was more resistant to polyanions, suggesting enhanced stability. Limited exposure of the TBP:DNA complex to proteases indicated that TBP conformation was altered on CldAMP-substituted DNA compared to control. Further, binding of transcription factor IIB to TBP was diminished on analog-containing TATA sequences. These results suggest normal TBP-binding interactions-specifically recognition, stability, and conformation-are disrupted by CldAMP insertion into eukaryotic promoter sequences.

AB - 2-Chlorodeoxyadenosine (CldAdo, Cladribine), a nucleoside analog used in the treatment of hairy cell leukemia, is phosphorylated and incorporated into DNA, but is not an absolute chain terminator. We hypothesized that the presence of a chlorine molecule projecting into the DNA minor groove would affect DNA:protein-binding interactions. Here, we investigated recognition of and binding to double-stranded CldAMP-substituted TATA promoter sequences by human TATA-binding protein (TBP) using mobility shift assays. Depending on the site, CldAMP in place of dAMP within a TATA sequence decreased in vitro TBP binding by ∼30% to 55% compared to control sites. When bound to a CldAMP-substituted TATA box, however, the TBP complex was more resistant to polyanions, suggesting enhanced stability. Limited exposure of the TBP:DNA complex to proteases indicated that TBP conformation was altered on CldAMP-substituted DNA compared to control. Further, binding of transcription factor IIB to TBP was diminished on analog-containing TATA sequences. These results suggest normal TBP-binding interactions-specifically recognition, stability, and conformation-are disrupted by CldAMP insertion into eukaryotic promoter sequences.

KW - Cancer drug

KW - Cladribine

KW - DNA minor groove

KW - Hairy cell leukemia

KW - Promoter sequence

KW - Protein conformation

KW - Protein:protein associations

KW - RNA polymerase II

KW - TATA-binding protein

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=33847653338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847653338&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2006.12.031

DO - 10.1016/j.abb.2006.12.031

M3 - Article

C2 - 17320040

AN - SCOPUS:33847653338

VL - 459

SP - 223

EP - 232

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 2

ER -